Platelet-Activating Factor (PAF) Antagonists Attenuate Inflammatory- Based Pain: Potential Cellular and Anatomical Sites of PAF Action

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 2, 2006-01 ,pp. : 129-133

Bentham Science Publishers

Access to resources Recommend Favorite

Ocular actions of platelet-activating factor: clinical implications

By Nitoda Eirini   Moschos Marilita M   Mavragani Clio P   Koutsilieris Michael  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 10, 2012-10 ,pp. : 1027-1039

Informa Healthcare

Access to resources Recommend Favorite

Endogenous corticosteroids mediate the neutrophilia caused by platelet-activating factor in the mouse

By Harris J.G.   Flower R.J.   Perretti M.  

European Journal of Pharmacology, Vol. 283, Iss. 1, 1995-09 ,pp. : 9-18

Elsevier

Access to resources Recommend Favorite

Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist

By Albert D.H.   Magoc T.J.   Tapang P.   Luo G.   Morgan D.W.   Curtin M.   Sheppard G.S.   Xu L.   Heyman H.R.   Davidsen S.K.   Summers J.B.   Carter G.W.  

European Journal of Pharmacology, Vol. 325, Iss. 1, 1997-04 ,pp. : 69-80

Elsevier

Access to resources Recommend Favorite

Effects of liposome-entrapped platelet-activating factor in the isolated rat trachea

By Costuleanu M.   Brailoiu E.   Filipeanu C.M.   Baltatu O.   Slatineanu S.   Saila L.   Nechifor M.   Branisteanu D.D.  

European Journal of Pharmacology, Vol. 281, Iss. 1, 1995-07 ,pp. : 89-92

Elsevier

Access to resources Recommend Favorite